Commissioning of a precision preclinical 200 kV x-ray irradiator based on modular adaptations

基于模块化改造的精密临床前200 kV X射线辐照器的调试

阅读:1

Abstract

BACKGROUND: Preclinical research in radiation oncology encompasses a range of methodologies, including in vitro cell studies and in vivo small animal experiments, as well as in silico studies to evaluate radiation-induced side effects and tumor responses. PURPOSE: This study addresses the need for high-precision x-ray irradiation solutions as reference for preclinical research. Modifications of an industrial kilovoltage x-ray unit, along with the commissioning of a commercial treatment planning system (TPS), aimed to enable reliable irradiation of small animals in a horizontal beam geometry. All advancements enhancing the irradiation framework are made available, offering cost-effective upgrades for existing systems. METHODS: An industrial kilovoltage x-ray unit was equipped with a dual collimation system, featuring a fixed primary and variable secondary collimators with aperture diameters of 5 to 30 mm. Additional modular adaptations were designed and manufactured, including a multimodal mouse bedding unit, a dedicated dosimetry phantom and a quality assurance (QA) phantom. Output factors, percentage depth dose curves and lateral dose profiles were acquired to generate a beam model in the TPSμ -RayStation 8B (RaySearch Laboratories, Stockholm, Sweden), using a diamond detector and radiochromic films. Treatment plans for 10 mice were created, evaluated via dose-volume metrics and the homogeneity index and subsequently dosimetrically compared to QA measurements through a gamma analysis with a 1%/ 1 mm acceptance criterion. RESULTS: The resulting beam model was validated within a maximum dose deviation of 1.7%. Aperture diameters close to potential target diameters were found to be effective for achieving sufficient target coverage in silico, as demonstrated for a 5 mm target with a homogeneity index of (9.9  ± 0.7)%. Dedicated QA measurements revealed a maximum dose deviation of 1.9% from the TPS and a median gamma passing rate of 100%, confirming the suitability of the proposed solution. CONCLUSIONS: Cost-effective adaptations for an kilovoltage x-ray irradiation framework were designed, manufactured and commissioned, and contribute to the accessibility of preclinical irradiation research. These components are integrated into a comprehensive preclinical particle beam platform.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。